期刊
CLINICAL & TRANSLATIONAL ONCOLOGY
卷 13, 期 5, 页码 294-300出版社
SPRINGER-VERLAG ITALIA SRL
DOI: 10.1007/s12094-011-0657-2
关键词
Glioma; Glioblastoma; Anti-angiogenesis
类别
There has been great interest in developing anti-angiogenic therapies for the treatment of patients with high-grade gliomas. In fact, some anti-angiogenic agents are now routinely used for the treatment of patients with glioblastoma. However, the use of these agents is largely based on trials which indicate an initial radiographic response, while it remains unclear whether any anti-angiogenic therapies tested to date have improved the overall survival of patients with malignant glial tumours. This manuscript reviews the landscape of anti-angiogenic therapy in glioma, with a focus on GBM, and demonstrates that further innovation is needed to determine the true utility of anti-angiogenic therapy.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据